4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-008849
Chief Financial Officer sold 1,388 shares at $12.66 ($17,568)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ruffo Frank Chief Financial Officer | 2022-02-09 | Sale | −1,388 | $12.66 | $17,568 | 172,359 | D: show line 1 in the form |
| Open-market sales · 1,388 sh · avg $12.66 · $17,568 | |||||||
Loading xslF345X03/doc4.xml…